IFC partnered with a leading international pharmaceutical company engaged in the development, manufacturing and supply of Anti-Retroviral (“ARV”) drugs to identify and develop local manufacturing opportunities of their products in selected African countries in partnership with local manufacturers. IFC wishes to engage a consultant/consulting firm (the “Consultant”) to complete the feasibility of a proposed API and finished drugs manufacturing facility to assist in selecting the optimal location between Cameroon and Kenya, which assessment will include an evaluation of the market, regulatory, technical and financial implementation aspects in each country respectively.